celiprolol has been researched along with Kidney Failure, Chronic in 2 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dosage reduction in patients with renal impairment does not seem to be necessary." | 1.28 | Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function. ( Frölich, M; Hartmann, C; Knauf, H; Krauss, D; Mutschler, E; Spahn-Langguth, H, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robson, RA | 1 |
| Bridgman, PG | 1 |
| Wells, JE | 1 |
| Bailey, RR | 1 |
| Lynn, KL | 1 |
| Hartmann, C | 1 |
| Frölich, M | 1 |
| Krauss, D | 1 |
| Spahn-Langguth, H | 1 |
| Knauf, H | 1 |
| Mutschler, E | 1 |
1 trial available for celiprolol and Kidney Failure, Chronic
| Article | Year |
|---|---|
The effect of celiprolol on glomerular filtration rate and renal blood flow in patients with chronic renal impairment and healthy volunteers.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Celiprolol; Female; Glomerular Filtration Rate; Huma | 1992 |
1 other study available for celiprolol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Celiprolol; Female; Humans; Kidney; | 1990 |